Ultralife Statistics
Total Valuation
Ultralife has a market cap or net worth of $92.98 million. The enterprise value is $133.83 million.
| Market Cap | 92.98M |
| Enterprise Value | 133.83M |
Important Dates
The last earnings date was Friday, August 7, 2026, before market open.
| Earnings Date | Aug 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Ultralife has 16.66 million shares outstanding. The number of shares has decreased by -0.70% in one year.
| Current Share Class | 16.66M |
| Shares Outstanding | 16.66M |
| Shares Change (YoY) | -0.70% |
| Shares Change (QoQ) | +0.34% |
| Owned by Insiders (%) | 42.24% |
| Owned by Institutions (%) | 32.77% |
| Float | 9.62M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.50 |
| Forward PS | 0.79 |
| PB Ratio | 0.69 |
| P/TBV Ratio | 1.22 |
| P/FCF Ratio | 45.95 |
| P/OCF Ratio | 18.19 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.54, with an EV/FCF ratio of 66.06.
| EV / Earnings | n/a |
| EV / Sales | 0.72 |
| EV / EBITDA | 10.54 |
| EV / EBIT | 18.23 |
| EV / FCF | 66.06 |
Financial Position
The company has a current ratio of 2.87, with a Debt / Equity ratio of 0.36.
| Current Ratio | 2.87 |
| Quick Ratio | 1.11 |
| Debt / Equity | 0.36 |
| Debt / EBITDA | 3.40 |
| Debt / FCF | 23.39 |
| Interest Coverage | 2.02 |
Financial Efficiency
Return on equity (ROE) is -4.91% and return on invested capital (ROIC) is 4.27%.
| Return on Equity (ROE) | -4.91% |
| Return on Assets (ROA) | 2.10% |
| Return on Invested Capital (ROIC) | 4.27% |
| Return on Capital Employed (ROCE) | 4.12% |
| Weighted Average Cost of Capital (WACC) | 7.87% |
| Revenue Per Employee | $276,165 |
| Profits Per Employee | -$9,661 |
| Employee Count | 678 |
| Asset Turnover | 0.86 |
| Inventory Turnover | 2.59 |
Taxes
| Income Tax | -2.98M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -17.58% in the last 52 weeks. The beta is 0.83, so Ultralife's price volatility has been lower than the market average.
| Beta (5Y) | 0.83 |
| 52-Week Price Change | -17.58% |
| 50-Day Moving Average | 6.02 |
| 200-Day Moving Average | 6.27 |
| Relative Strength Index (RSI) | 35.48 |
| Average Volume (20 Days) | 36,595 |
Short Selling Information
The latest short interest is 110,788, so 0.66% of the outstanding shares have been sold short.
| Short Interest | 110,788 |
| Short Previous Month | 92,497 |
| Short % of Shares Out | 0.66% |
| Short % of Float | 1.15% |
| Short Ratio (days to cover) | 2.40 |
Income Statement
In the last 12 months, Ultralife had revenue of $187.24 million and -$6.55 million in losses. Loss per share was -$0.39.
| Revenue | 187.24M |
| Gross Profit | 45.65M |
| Operating Income | 7.36M |
| Pretax Income | -9.63M |
| Net Income | -6.55M |
| EBITDA | 12.73M |
| EBIT | 7.36M |
| Loss Per Share | -$0.39 |
Balance Sheet
The company has $6.66 million in cash and $47.51 million in debt, with a net cash position of -$40.85 million or -$2.45 per share.
| Cash & Cash Equivalents | 6.66M |
| Total Debt | 47.51M |
| Net Cash | -40.85M |
| Net Cash Per Share | -$2.45 |
| Equity (Book Value) | 132.60M |
| Book Value Per Share | 7.95 |
| Working Capital | 69.80M |
Cash Flow
In the last 12 months, operating cash flow was $5.13 million and capital expenditures -$3.10 million, giving a free cash flow of $2.03 million.
| Operating Cash Flow | 5.13M |
| Capital Expenditures | -3.10M |
| Depreciation & Amortization | 5.37M |
| Net Borrowing | -6.50M |
| Free Cash Flow | 2.03M |
| FCF Per Share | $0.12 |
Margins
Gross margin is 24.38%, with operating and profit margins of 3.93% and -3.50%.
| Gross Margin | 24.38% |
| Operating Margin | 3.93% |
| Pretax Margin | -5.15% |
| Profit Margin | -3.50% |
| EBITDA Margin | 6.80% |
| EBIT Margin | 3.93% |
| FCF Margin | 1.08% |
Dividends & Yields
Ultralife does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.70% |
| Shareholder Yield | 0.70% |
| Earnings Yield | -7.02% |
| FCF Yield | 2.18% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ultralife has an Altman Z-Score of 1.92 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.92 |
| Piotroski F-Score | 4 |